Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Capitol Capsule: Rare Diseases: The Path To Precision Medicine

This article was originally published in Scrip

Executive Summary

The path to achieving the promise of precision medicine – prevention and treatment strategies that take individual variability in genes, environment and lifestyle into account – must go through the discovery, research and development processes of rare diseases, a panel of experts and advocates said last week during a Capitol Hill briefing hosted by the House Rare Disease Congressional Caucus, headed by Reps. Leonard Lance (R-NJ) and Joe Crowley (D-NY).

Advertisement

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC030258

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel